Homepage

J&J blood clot risk is less than 1 in a million. Don’t be skeptical about the vaccine, docs say.
April 14, 2021
J&J blood clot risk is less than 1 in a million. Don’t be skeptical about the vaccine, docs say.
Nj.com

Read More › about J&J blood clot risk is less than 1 in a million. Don’t be skeptical about the vaccine, docs say.

Conversations with CABM Director: An interview with Dr. Martin Blaser
April 7, 2021
Conversations with CABM Director: An interview with Dr. Martin Blaser
YouTube

Read More › about Conversations with CABM Director: An interview with Dr. Martin Blaser

Life in N.J. will never be the same after COVID. Here’s what ‘new normal’ could look like.
April 2, 2021
Life in N.J. will never be the same after COVID. Here’s what ‘new normal’ could look like.
New Jersey Advance Media for NJ.com

Read More › about Life in N.J. will never be the same after COVID. Here’s what ‘new normal’ could look like.

15M Johnson & Johnson vaccine doses ruined in manufacturing error
April 1, 2021
15M Johnson & Johnson vaccine doses ruined in manufacturing error
NJ Spotlight News

Read More › about 15M Johnson & Johnson vaccine doses ruined in manufacturing error

Infant Antibiotic Exposure Can Affect Future Immune Responses Toward Allergies
April 1, 2021
Infant Antibiotic Exposure Can Affect Future Immune Responses Toward Allergies
Rutgers Today

Read More › about Infant Antibiotic Exposure Can Affect Future Immune Responses Toward Allergies

Conversations with CABM Director: An interview with Dr. Anat Kreimer
March 31, 2021
Conversations with CABM Director: An interview with Dr. Anat Kreimer
YouTube

Read More › about Conversations with CABM Director: An interview with Dr. Anat Kreimer

Spotlight

Conversations with CABM Director: An interview with Dr. Martin Blaser
Martin Blaser and Ann Stock having a conversation.

Conversations with CABM Director: An interview with Dr. Martin Blaser

Associate Director Ann Stock interviews CABM Director Martin Blaser

Read More › about Conversations with CABM Director: An interview with Dr. Martin Blaser